Abstract Information


In general, all posters with odd numbers will be presented on Sunday, while all posters with even numbers will be presented on Monday. There are some exceptions so please refer to the original notification email you received. 

POSTER SPECIFICATIONS: You will be assigned one half of a standard North American poster board. Your poster must fit in an area no larger than 45″ x 45″ (115cm x 115 cm) and can be attached with pushpins (supplied onsite) or Velcro. You may mount your poster as early as 11:00am on your assigned day. We ask that you stand with your poster during the session and remove it at the end of the session. All posters not removed will be discarded.



Please note the following important submission guidelines:
  1. The abstract deadline has been extended to February 1, 2018 at 11:59pm CST.
  2. Abstracts are limited to 250 words; figures and tables are not allowed.
  3. Abstract titles should use sentence case (i.e., only the first letter of the title should be capitalized)
  4. The body of the abstract should be in a single paragraph. If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS)
Abstracts of original research will be accepted in the following categories:
  • ATRT
  • Medulloblastoma – Basic/Translational
  • Medulloblastoma –  Clinical
  • Other Embryonal Tumors
  • Craniopharyngioma/Rare Tumors
  • Early Phase/Drug Discovery
  • Ependymoma
  • Epidemiology
  • Germ Cell Tumors
  • Diffuse Midline Glioma/DIPG
  • High-Grade Glioma
  • Immune Therapy
  • Low-Grade Glioma
  • Neurofibromatosis Associated Tumors (including plexiforms)
  • Neuro-Oncology in Low/Middle Income Countries
  • Neurosurgery
  • Nursing – Clinical
  • Nursing – Research
  • Preclinical Models
  • Pharmacokinetics
  • QoL/Survival/Rehab
  • Radiation Oncology
  • Radiology
  • Social Work/Patient Support
  • Tumor Biology/Pathology (not fitting a specific disease category)